$10.98
4.27% yesterday
NYSE, Jun 13, 10:10 pm CET
ISIN
US1638511089
Symbol
CC

Chemours Co. Stock price

$10.98
-0.80 6.79% 1M
-8.06 42.33% 6M
-5.92 35.03% YTD
-14.58 57.04% 1Y
-4.39 28.56% 5Y
-9.87 47.34% 10Y
-9.87 47.34% 20Y
NYSE, Closing price Fri, Jun 13 2025
-0.49 4.27%
ISIN
US1638511089
Symbol
CC

Key metrics

Market capitalization $1.72b
Enterprise Value $5.36b
P/E (TTM) P/E ratio 54.62
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.92
P/S ratio (TTM) P/S ratio 0.30
P/B ratio (TTM) P/B ratio 2.96
Dividend yield 8.72%
Last dividend (FY24) $1.00
Revenue growth (TTM) Revenue growth -0.68%
Revenue (TTM) Revenue $5.80b
EBIT (operating result TTM) EBIT $427.00m
Free Cash Flow (TTM) Free Cash Flow $-797.00m
Cash position $464.00m
EPS (TTM) EPS $0.21
P/E forward 8.12
P/S forward 0.29
EV/Sales forward 0.91
Short interest 12.52%
Show more

Is Chemours Co. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Chemours Co. Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Chemours Co. forecast:

7x Buy
54%
5x Hold
38%
1x Sell
8%

Analyst Opinions

13 Analysts have issued a Chemours Co. forecast:

Buy
54%
Hold
38%
Sell
8%

Financial data from Chemours Co.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
5,801 5,801
1% 1%
100%
- Direct Costs 4,700 4,700
2% 2%
81%
1,101 1,101
10% 10%
19%
- Selling and Administrative Expenses 566 566
57% 57%
10%
- Research and Development Expense 108 108
2% 2%
2%
745 745
616% 616%
13%
- Depreciation and Amortization 318 318
6% 6%
5%
EBIT (Operating Income) EBIT 427 427
319% 319%
7%
Net Profit 31 31
109% 109%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Chemours Co. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Chemours Co. Stock News

Neutral
Business Wire
one day ago
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Appoints Matthew Conti as Chief Human Resources Officer.
Neutral
Business Wire
4 days ago
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Appoints Technology and Data Center Infrastructure Industry Vet Nathan Blom as Vice President of Liquid Cooling Growth Portfolio.
Neutral
Business Wire
26 days ago
WILMINGTON, Del.--(BUSINESS WIRE)--Chemours & DataVolt Announce Agreement to Accelerate Adoption of Liquid Cooling Solutions & Support Broader Innovation for AI Data Centers.
More Chemours Co. News

Company Profile

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. It operates through the following segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment produces titanium dioxide. The Fluoroproducts segment supplies refrigerants and industrial fluoropolymer resins. The Chemical Solutions segment provides chemicals used in gold production, oil refining, agriculture, and industrial polymers. The firm offers refrigerants, industrial fluoropolymer resins, sodium cyanide, performance chemicals and intermediates, and titanium dioxide pigments to the plastics and coatings, refrigeration and air conditioning, general industrial, electronics, mining, and oil refining markets. The company was founded on February 18, 2014 and is headquartered in Wilmington, Delaware.

Head office United States
CEO Denise Dignam
Employees 6,000
Founded 2014
Website www.chemours.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today